The Journal of
Clinical Psychiatry

Depression (MDD)

Insights April 6, 2021

Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics

Madhukar H. Trivedi, MD; George I. Papakostas, MD; W. Clay Jackson, MD, DipTh; Roueen Rafeyan, MD, DFAPA, FASAM

J Clin Psychiatry 2020;81(3):OT19037BR3

Learn how to talk with patients who have major depressive disorder about antipsychotic treatment in a way that is clear and balanced and addresses patients’ potential concerns about taking antipsychotic medication.

Read the eReport

About the Authors

Save

Cite

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Insights

Patient Functioning and Life Engagement: Treatment Goals in MDD

September 7, 2022

Patients with MDD often report lack of motivation and energy and a feeling of disengagement from their own lives. Here, experts discuss treatment strategies that may be favorable for...

Michael E. Thase, Christoph U. Correll, Roger S. McIntyre, et al

Insights

Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy

May 17, 2022

Dr Lam explains in this video how for patients with depressive disorders treated with pharmacotherapy, measurement-based care is effective in decreasing symptom severity, promoting remission, and improving medication adherence.

Raymond W. Lam

Insights

Progression of Symptoms Over the Course of Bipolar Disorder

April 13, 2021

Dr Joseph F. Goldberg discusses how symptoms and clinical presentation change over time in people with bipolar disorder, beginning from the prodromal phase

Joseph F. Goldberg

Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics

About the Authors

Read the Current Issue

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Valbenazine in Elderly Adults With Tardive Dyskinesia

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Psychosocial Correlates of Optimism among US Military Veterans

ELSEWHERE:

FOLLOW US:

Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics

About the Authors

Read the Current Issue

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Valbenazine in Elderly Adults With Tardive Dyskinesia

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Psychosocial Correlates of Optimism among US Military Veterans

Related Articles

Patient Functioning and Life Engagement: Treatment Goals in MDD

Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy

Progression of Symptoms Over the Course of Bipolar Disorder

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles